| Applera Corporation comprises two operating groups. The Celera
Genomics Group, headquartered in Rockville, MD, is engaged
principally in integrating advanced technologies to create
therapeutic discovery and development capabilities for internal
use and for its customers and collaborators. Celera's businesses
are its online information business and its therapeutics
discovery business. The online information business is a leading
provider of information based on the human genome and other
biological and medical information. Through the therapeutic
discovery business, Celera intends to leverage its genomic and
proteomic capabilities to identify drug targets and diagnostic
marker candidates, and to discover novel therapeutic candidates.
The Applied Biosystems Group (NYSE:ABI) develops and markets
instrument-based systems, reagents, software, and contract
services to the life science industry and research community.
Applied Biosystems is headquartered in Foster City, CA, and
reported sales of $1.6 billion during fiscal 2001. Celera
Diagnostics has been established as a joint venture between
Applied Biosystems and Celera Genomics. This new venture is
focused on discovery, development and commercialization of novel
diagnostic tests. Information about Applera Corporation,
including reports and other information filed by the company
with the Securities and Exchange Commission, is available on the
World Wide Web at www.applera.com, or by telephoning
800.762.6923. Information about Celera is available on the World
Wide Web at www.celera.com. |
